World Wires · story 22115 · unverified · 1 source(s)

Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PHILADELPHIA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and l

Open in the desk

Coverage

• Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire: public companies · tier D · clear net · 2026-10-05 20:01 UTC

What this site indexes